Back to Top
Charles H. Hood Foundation | PRI Company Update: Prapela Awarded NIH Grant
By identifying innovative pediatric advancements and providing funding in the critical phases of development, we are able to expedite high-impact breakthroughs that improve the health and lives of millions.
17643
post-template-default,single,single-post,postid-17643,single-format-standard,ajax_fade,page_not_loaded,,qode-title-hidden,qode-child-theme-ver-1.0.0,qode-theme-ver-10.0,wpb-js-composer js-comp-ver-4.12,vc_responsive

PRI Company Update: Prapela Awarded NIH Grant

We are thrilled to share the great news that Prapela has been awarded its first Small Business Innovation Research (SBIR) grant from The National Institute on Drug Abuse (NIDA). The grant will be used to advance the development of the Prapela SVS Hospital Bassinet for the treatment of newborns diagnosed with Neonatal Abstinence Syndrome (NAS) – the condition newborns experience as they withdraw from opioids they were exposed to during pregnancy.  Read more hereCongratulations, Prapela!!